Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARID1A and TERT promoter mutations in dedifferentiated meningioma.

Cancer genetics - 1 Jun 2015

Abedalthagafi Malak S, Bi Wenya Linda, Merrill Parker H, Gibson William J, Rose Matthew F, Du Ziming, Francis Joshua M, Du Rose, Dunn Ian F, Ligon Azra H, Beroukhim Rameen, Santagata Sandro

Abstract excerpt

Unlike patients with World Health Organization (WHO) grade I meningiomas, which are considered benign, patients with WHO grade III meningiomas have very high mortality rates. The principles underlying tumor progression in meningioma are largely unknown, yet a detailed understanding of these mechanisms will be required for effective management of patients with these high grade lethal tumors. We present a case of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease Progression
Share to DNA-Binding Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Meningeal Neoplasms

Share to Meningioma

Share to Neoplasm Recurrence, Local

Share to Nuclear Proteins

Share to Promoter Regions, Genetic

Share to Telomerase

Source

Open in PubMed Open full text

Identifiers

PMID: 25963524
DOI: 10.1016/j.cancergen.2015.03.005
PMCID: PMC4882906

Genes

TERT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARID1A and TERT promoter mutations in dedifferentiated meningioma.PMID 25963524Read ↗

TERT promoter mutations in primary and secondary WHO grade III meningiomaSemantic proximity Read ↗

High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.Semantic proximity Read ↗

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolutionSemantic proximity Read ↗

Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical OutcomeSemantic proximity Read ↗

Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas.Semantic proximity Read ↗

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.Semantic proximity Read ↗

Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumorsSemantic proximity Read ↗

[Pathological Diagnosis and Genetic Alterations of Meningioma].Semantic proximity Read ↗

Progression-Free Survival and Molecular Features of Recurrent Intracranial Meningiomas: A Single-Center Retrospective StudySemantic proximity Read ↗

Multiomic and clinical analysis of multiply recurrent meningiomas reveals risk factors, underlying biology, and insights into evolutionSemantic proximity Read ↗

TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.Semantic proximity Read ↗

Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnosticSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.